foxo4-dri senolytic animal model 2023 2024 FOXO4-DRI: The Peptide That Targets Zombie Cells and Aging – Revolution Health & Wellness Senolytic therapeutics: An emerging treatment
Senolytic therapeutics: An emerging treatment modality for osteoarthritis ScienceDirect Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $6.79 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14



